Peter Holm Tygesen
Chief Executive Officer at Croda Biosector A/S
Profile
Peter Holm Tygesen is currently the Chief Executive Officer & Head-Sales at Croda Biosector A and the Managing Director & Director at Croda Denmark.
A since 2016.
He previously worked as a Principal at H.
Lundbeck A, Vice President-Pharmaceutical Development & Supply at Astion Pharma A, and Chief Scientific Officer at Egalet Ltd.
from 2008 to 2011.
Peter Holm Tygesen active positions
| Companies | Position | Start |
|---|---|---|
Croda Biosector A/S
 Croda Biosector A/S Chemicals: Major DiversifiedProcess Industries Croda Biosector A/S produces immunological and vaccine adjuvants. The firm's brands include Alhydrogel, Adju-Phos and Quil-A. The company was founded in April 1939 and is headquartered in Ballerup, Denmark. | Chief Executive Officer | - |
Croda Denmark A/S
 Croda Denmark A/S BiotechnologyHealth Technology Croda Denmark A/S is a Danish company that specializes in researching and developing human and veterinary vaccines. The private company is based in Frederikssund, Denmark. The company was founded in 2014. Peter Holm Tygesen has been the CEO of the company since 2016. | Chief Executive Officer | 29/02/2016 |
Former positions of Peter Holm Tygesen
| Companies | Position | End |
|---|---|---|
Astion Pharma A/S
 Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | President | 08/08/2011 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| Private companies | 4 |
|---|---|
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Health Technology |
Croda Biosector A/S
Croda Biosector A/S Chemicals: Major DiversifiedProcess Industries Croda Biosector A/S produces immunological and vaccine adjuvants. The firm's brands include Alhydrogel, Adju-Phos and Quil-A. The company was founded in April 1939 and is headquartered in Ballerup, Denmark. | Process Industries |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
Croda Denmark A/S
Croda Denmark A/S BiotechnologyHealth Technology Croda Denmark A/S is a Danish company that specializes in researching and developing human and veterinary vaccines. The private company is based in Frederikssund, Denmark. The company was founded in 2014. Peter Holm Tygesen has been the CEO of the company since 2016. | Health Technology |
- Stock Market
- Insiders
- Peter Holm Tygesen
